About PGT-A
PGT-A stands for Preimplantation Genetic Testing for Aneuploidy.
PGT-A is a genetic study of the embryos produced during patients’ IVF cycle which has a goal of helping them have a successful pregnancy and a healthy baby.
PGT-A is a preventative measure used to identify chromosomal abnormalities in the embryo, even if there’s no known evidence of a genetic abnormality in either parent. The procedure screens for chromosomal abnormalities, such as Down Syndrome (Trisomy 21), as well as abnormalities in chromosome position (translocations).
PGT-A may help to:
– Reduce the chance of having a miscarriage
– Reduce the risk of an abnormal pregnancy
– Reduce the time and cost to achieve a healthy baby by helping choose the best embryo(s) to transfer
– Reduce the risks associated with the transfer of multiple embryos at a time
PGT-A with NGS
Every decade or so a reproductive technology comes along that revolutionizes infertility treatment. PGT-A by Next Generation Sequencing (NGS) is one such technology. PGT-A with NGS is a highly consistent platform and is the future of genetic and embryo screening.